| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 11,474 | 6,724 |
| Depreciation and amortization | 2,525 | 1,229 |
| Stock-based compensation expense | 8,292 | 4,526 |
| Provision for excess and obsolete inventory | 1,790 | 711 |
| Amortization of operating lease right-of-use assets | 601 | 243 |
| Deferred income taxes | 15 | 7 |
| Earnings from equity method investments | 398 | 293 |
| Change in fair value of contingent consideration | 0 | 0 |
| Other non-cash items | -138 | -140 |
| Accounts receivable | -6,305 | 8,512 |
| Inventory | 5,982 | 1,046 |
| Prepaid expenses and other assets | 3,503 | 5,084 |
| Operating leases | -281 | -64 |
| Accounts payable and accrued expenses | 2,911 | 6,321 |
| Deferred revenue | -13,275 | -777 |
| Net cash provided by operating activities | 10,612 | 4,125 |
| Purchases of property, plant and equipment | 2,206 | 814 |
| Cash paid to settle megatran contingent consideration liability-Megatran | 0 | - |
| Cash paid for megatran acquisition, net of cash acquired-Megatran | 0 | - |
| Change in other assets | -83 | -79 |
| Net cash used in investing activities | -2,123 | -735 |
| Repurchase of treasury stock | 0 | - |
| Repayment of debt | 0 | 0 |
| Employee taxes paid related to net settlement of equity awards | 0 | 0 |
| Proceeds from exercise of employee stock options and espp | 242 | - |
| Proceeds from public equity offering, net of offering expenses | 124,577 | 124,577 |
| Net cash provided by (used in) financing activities | 124,819 | 124,577 |
| Effect of exchange rate changes on cash | 67 | 71 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 133,375 | 128,038 |
| Cash and cash equivalents at beginning of period | 85,381 | - |
| Cash and cash equivalents at end of period | 218,756 | - |
AMERICAN SUPERCONDUCTOR CORP DE (AMSC)
AMERICAN SUPERCONDUCTOR CORP DE (AMSC)